Related Experiment Video
Updated: Jun 21, 2025
13:11
Optimized Analysis of DNA Methylation and Gene Expression from Small, Anatomically-defined Areas of the Brain
Published on: July 12, 2012
18.8K
sciMET-cap: high-throughput single-cell methylation analysis with a reduced sequencing burden
Sonia N Acharya1, Ruth V Nichols1, Lauren E Rylaarsdam1
1Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
Genome Biology
|July 10, 2024
Summary
New DNA methylation sequencing (sciMET-cap) reduces read burden for single-cell epigenome analysis. This method enables cell type assignment and genome-wide differentially methylated region calling with fewer reads.
Area of Science:
- Epigenetics
- Genomics
- Molecular Biology
Background:
- DNA methylation is crucial for mammalian epigenome regulation in development and disease.
- High-throughput single-cell DNA methylation assays (sciMET) are powerful but require significant sequencing.
- The high sequencing burden limits scalability for genome-wide DNA methylation studies.
Purpose of the Study:
- To develop a targeted enrichment method (sciMET-cap) for single-cell DNA methylation analysis.
- To reduce the sequencing reads required per cell while retaining informative data.
- To enable efficient cell type assignment and differential methylation analysis.
Main Methods:
- Leveraging target enrichment with the sciMET assay.
- Capturing sufficient single-cell DNA methylation information with reduced sequencing.
- Analyzing accumulated off-target coverage for downstream analyses.
Main Results:
- sciMET-cap significantly reduces the sequencing burden per cell.
- The method allows for accurate cell type assignment.
- Genome-wide differentially methylated region calling is achievable for cell clusters as small as 115 cells.
Conclusions:
- sciMET-cap offers a more scalable and cost-effective approach to single-cell DNA methylation analysis.
- This technique facilitates robust epigenomic studies in complex biological systems.
- The method was successfully characterized on human peripheral blood mononuclear cells (PBMCs) and brain tissue.
